Penn's Kiran Musunuru spoke with The Inquirer about the future of CRISPR technology.

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

Six months into his second term, 42% of Americans approve of the job President Trump is doing, a new CBS News poll finds.

SHOPPING: Take charge of your health with help from Hims, the weight loss program that puts your specific needs front and ...

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

Our data show mitochondrial diseases affect ≈1 in 5000 newborns and cost families ...